Media Summary: In this deep-dive, we analyze the landmark Dr Guy Goodwin, our Chief Medical Officer, talks about COMPASS's Encouraging trial data is instilling both confidence and capital back into the psychedelic drug market, with estimates suggesting ...
Compass Pathways Phase 3 Breakthrough - Detailed Analysis & Overview
In this deep-dive, we analyze the landmark Dr Guy Goodwin, our Chief Medical Officer, talks about COMPASS's Encouraging trial data is instilling both confidence and capital back into the psychedelic drug market, with estimates suggesting ... Shares of companies involved in psychedelic-tied therapies surged Monday after President Donald Trump signed an executive ...
